#MultiOMics
Epigenetics Update - Cross-species multiomic atlas of the primate basal ganglia www.cell.com/cell/fulltex...

Ed S. Lein & Trygve E. Bakken (Allen Institute, Brain Health) in Cell

#Epigenetics #Chromatin #MultiOmics #BrainCellAtlas
---

Gain deeper insights into gene regulation; epigenometech.com
November 17, 2026 at 12:56 PM
Machine Learning and Multiomics in Precision Medicine: From Genetic Variants to Biomarker Discovery
ML-Driven Variant Annotation: What Works Today? Multiomics and Pharmacogenomics: Progress Toward Personalized Treatment Biomarker Discovery: From Predictive Models to Clinical Validation What Remains Aspirational? Future Directions: Building Trustworthy Multiomics Models References and Further Reading Multiomics and machine learning are advancing genetic variant interpretation, pharmacogenomics, and biomarker discovery, offering new opportunities for precision medicine. However, clinical adoption depends on rigorous validation, reproducibility, population diversity, and demonstrated clinical utility. Image credit: Jack_the_sparow/Shutterstock.com Genome sequencing has become faster and cheaper, so the challenge now is to reliably interpret variants and link them to disease. Combining multiomics with machine learning (ML) has expanded what variant interpretation and pharmacogenomics can achieve. This article examines established machine learning applications in multiomics for research and clinical decision support and considers what lies ahead for the field.1,3,4 Introduction: Connecting Genetic Variants to Clinical Insight Sequencing technology has now made it routine to catalog a patient's genetic variation. However, interpretation of variants found in whole-genome sequences still presents challenges. Many missense variants are filed as variants of uncertain significance because evidence for or against harm is insufficient. Whole-genome and exome testing for rare Mendelian conditions has been reported to yield a diagnosis in fewer than 25% of patients.1,2 Multi-omics...
www.news-medical.net
November 17, 2026 at 6:38 PM
Join us tomorrow at 12.00 at UZH Irchel (Y21-F65) or online. Hannah van Hove (UZH) will share how tissue microenvironments shape microglia in the brain's circumventricular organs, while Alexander Jurkowitsch (Bio-Techne Spatial) will introduce the applications of COMET spatial multiomics technology.
Please join us on November 19th at 12.00 for exciting talks from Dr. Hannah van Hove, who will talk about mapping microglia and how tissue micro-environments influence microglia, and Alexander Jurkowitsch, MSc, who will present about spatial transcriptomics with COMET. See our flyer for details.
November 18, 2026 at 11:02 AM
Epigenetics Update - A single-cell and spatial 3D multi-omic atlas of developing human basal ganglia www.cell.com/cell/fulltex...

neurome.bsky.social, Jason Ernst, Mercedes F. Paredes, chongyuanluo.bsky.social in Cell

#Epigenetics #SingleCell #MultiOmics #Chromatin
---

epigenometech.com
November 17, 2026 at 4:15 PM
#biocityturkunnouncement 47/26

This week
* MBC Bioinformatics Consultation 17Nov at 13:00
* Frontiers of Science 19Nov at 12:00
* Microbiome Meets Multiomics Symposium 19–20Nov
* CellCom Seminar 20Nov at 10:00

all upcoming events in bit.ly/4iH82wp

@utu.fi @inflames-flagship.bsky.social
November 16, 2026 at 7:13 AM
We're at Neuroscience 2026!

Visit Metabolon at Booth #212 to learn about NeuroMet, our emerging neurodegeneration consortium, and new multiomics capabilities connecting metabolic changes with protein and genetic networks.

📍 Booth 212

#SfN26
November 16, 2026 at 1:57 PM
Discoveries in single-cell multiomics reveal the complex transcription networks gover… PMID:42436193, Nat Commun 2026, @NatureComms @OTSociety @NAR_Open https://doi.org/10.1038/s41467-026-75521-8 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Single cell multiomics unravel the transcription networks controlling the different EMT tumor states | Nature Communications
Epithelial-to-mesenchymal transition (EMT) is a dynamic process during which cells lose their epithelial characteristics and acquire mesenchymal traits. In cancer, EMT is closely associated with tumor initiation, progression, invasion, metastasis, and therapy resistance. Rather than being a binary state switch, EMT encompasses a spectrum of tumor states with distinct functional properties. However, the transcription factors (TFs) that govern transitions between these EMT states remain poorly defined. Here, using multi-omic approaches combining single-cell RNA-seq and single-cell ATAC-seq, we delineate the transcriptomic and chromatin landscapes of distinct EMT states in a mouse model of skin squamous cell carcinoma (SCC). Through CRISPR/Cas9-mediated loss-of-function studies coupled with in vitro and in vivo functional assays, we identify TFs regulating specific EMT states. Klf5 and Pitx1 control the early stages of EMT and are essential for metastasis formation. In contrast, Nfatc1 an
doi.org
November 15, 2026 at 9:00 PM
Multi-omics reveals immune pathways in Leptospira infection:

🧪 5,800+ genes, 362 proteins identified
💥 Key factors: SERPINA1, BASP1 enhanced
🧫 Neutrophil activation spotlighted

https://tnyp.me/ENh1O5A4/s?v=ygf7n5

#Leptospirosis #MultiOmics #ImmuneResponse
November 16, 2026 at 11:45 AM
Cold cases in biology, meet Epi Multiome (aka MO). Same-cell RNA-seq and ATAC-seq readouts from the same cell show what’s active and why. Follow along as we dive into the publication case files: https://10xgen.com/28u

#OnTheCaseWithMO #MultiOmics
November 17, 2026 at 8:00 PM
Fast, reliable, multiomics sample prep.

See what Phil Lorenzi had to say about Si-Trap and how it transformed the way he views sample prep.

We are proud to support researchers with solutions that simplify sample preparation.

#Multiomics #Proteomics #Lipidomics #SamplePrep #ProtiFi #SiTrap #LCMS
November 17, 2026 at 3:31 PM
Dario Bressan (Head of SPACE, University of Cambridge) will discuss the development and application of integrated spatial multi-omics at The Festival of Genomics and Biodata in London this January. Register now: hubs.la/Q04ynt4G0
#MultiOmics #SpatialBiology #FOG2027
November 16, 2026 at 12:58 PM
Last week in Jakarta was one for the books. 📚 With Velgen Technik at the 3rd ASEAN Pathology Conference 2026 (Indonesian Chapter), we showed off AVITI24™ 5D multiomics and VITARI™, and Aaron Lin, PhD, spoke on end-to-end sequencing. 🧬

#AVITI24 #VITARI #Multiomics
November 16, 2026 at 6:20 PM
Discover how emerging research is transforming the future of precision medicine and Alzheimer's care.

🔗 Register today to join us for The Multiomics of Aging and Alzheimer’s Disease: https://ow.ly/9mIT5106yKC
November 13, 2026 at 6:36 PM
🎬 The Multiomics Showcase wrapped. The recordings are live.

Stanford, bit.bio, and MSKCC shared real biological stories, from same-cell multiomics with Cytos™️ to spatial variant detection in tissue with Panos™.

Watch on demand: https://bit.ly/4iQ8cQH.

#Multiomics #Cytos #Panos
November 13, 2026 at 7:32 PM
The next pandemic may be detected by algorithms before hospitals.

This review highlights how #AI, genomics, and #multiomics improve outbreak prediction, pathogen tracking, and resistance monitoring, advancing precision #PublicHealth.

#OpenAccess #DIT_Journal: doi.org/10.1016/j.dc...
November 13, 2026 at 8:01 AM
Learn about single-cell epigenetic profiling with our guide to single-cell CUT&Tag/Paired-Tag, which provides comparisons to other methods and bioinformatic insight

#Epigenetics #Multiomics #CUTandTag #10XGgenomics #ChIPSeq #SingleCell #PairedTag

Learn more here: u.epigenome.us/mHSAqLpl
November 13, 2026 at 3:01 PM
Multiomics study of 64 male PWH and 26 controls found INSTI switching lowered thyroxine and raised N-acetylputrescine across groups; TTR best predicted weight gain.
Metabolic Mechanisms of Integrase Strand Transfer Inhibitor-Associated Weight Gain: A Multiomics Study in Male People With HIV
Integrase strand transfer inhibitors (INSTI) are recommended as first-line antiretroviral therapy for human immunodeficiency virus (HIV) infection, yet are frequently associated with excessive weight gain.MethodsWe conducted a multiomics study on male people with HIV (PWH). A total of 64 male PWH were enrolled and stratified based on their therapeutic history and weight changes over the first year (G1 receiving INSTI with weight gain ≥ 5%; G2 switching to INSTI with weight gain ≥ 5%; and G3 switching to INSTI without weight gain). Integrase strand transfer inhibitor-based regimens included bictegravir-, elvitegravir-, and dolutegravir-containing combinations. Twenty-six healthy male controls were also included. Plasma untargeted metabolomics and proteomics were analyzed longitudinally. Machine learning models were employed to integrate multiomics data and identify predictive biomarkers.ResultsMetabolomic analysis revealed that switching to INSTI induced a generalized hypometabolic state, characterized by a universal decline in thyroxine and an increase in N-acetylputrescine across all switching groups, independent of weight outcomes. In contrast, proteomic profiling identified distinct molecular drivers specific to the weight-gain groups. Random forest modeling identified transthyretin (TTR) as the top predictive biomarker among pre-INSTI multiomics features.ConclusionsOur integrated multiomics approach reveals that INSTI-based regimens induce universal metabolic changes. The change of thyroxine and the predictability of TTR in multiomics studies show the critical role of thyroxine metabolism in INSTI-associated weight gain.
academic.oup.com
November 17, 2026 at 1:00 PM
Our expansion of single-cell epigenetics assays continues!
The Epigenome Technologies scCUT&Tag assay is now compatible with the BD Rhapsody platform

#Epigenetics #BDrhapsody #CUTandTag #Chromatin #Multiomics #Singlecell #CUTandRUN #ChIPseq #ATACseq

Learn more here: u.epigenome.us/NYjSGQao
November 12, 2026 at 9:07 PM
Recently I visited Paris and Orlando for two great conferences #ISSjD2026 #ACR26
Shared our SjD GWAS (SGENE) & early SjD multiomics (AMP-AIM), with GREAT, RRF & ARP President's awards along the way 🏆
SjD research is speeding up, and we're keeping anti-Ro− patients in focus. Thanks, team & mentor!
November 14, 2026 at 4:13 PM
Genomics is only one layer of the story. On the Multi-omics Stage at FOG London, discover how proteomics, AI and computational biology are linking variation to function, uncovering drug targets and advancing precision medicine. Register : hubs.la/Q04ynt4G0
#MultiOmics #DrugDiscovery #FOG2027
November 18, 2026 at 12:09 PM
Thinking about a CRISPR or drug screen with Cytos™? You probably have questions. 🤔

Our getting started guide covers what to think about before you plan, so you can start with answers instead of guesswork. 📘

Download it: https://bit.ly/48uCqEf.

#Cytos #CRISPRScreening #Multiomics
November 18, 2026 at 5:37 PM
#FRA
A pan-genomic pipeline links structural variation in forest-tree secondary metabolism to multi-omics hub genes and ADMET-guided docking, closing the loop from genome to drug lead.
Details: https://www.maxapress.com/article/doi/10.48130/fra-0026-0016
#PanGenome #SecondaryMetabolism #MultiOmics
November 18, 2026 at 2:23 AM
#KidneyOrganoids face serious maturation limits.
This review outlines how organ-on-a-chip tools and #MultiOmics may overcome poor vascularization and batch effects to advance translational medicine. #InheritedKidneyDiseases
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
November 12, 2026 at 11:30 PM